• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - JUGULAR; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - JUGULAR; VENA CAVA FILTER Back to Search Results
Catalog Number RF320J
Device Problems Malposition of Device (2616); Patient Device Interaction Problem (4001)
Patient Problem Abdominal Pain (1685)
Event Date 07/21/2017
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: the device was not returned for evaluation.The medical records included images.The image review was documented in the medical records.Medical records were provided and reviewed.Approximately eight months and thirty days later, computed tomography (ct) revealed that a filter was noted within the infra renal inferior vena cava.Approximately eight months and sixteen days later, the patient reported to the medical center with abdominal pain.On the same day, a computed tomography (ct) revealed that a bard inferior vena cava filter was in stable location, below the renal veins.No filter migration or bend/fracture was noted.The filter was tilted anteriorly with its cone lay near the wall of the inferior vena cava.Several of the arms and legs of the filter had penetrated through the inferior vena cava into the pericaval/mesenteric fat.One leg penetrated the duodenum.One leg penetrated the disc.Therefore, the investigation is confirmed for alleged perforation of the inferior vena cava (ivc) and filter tilt.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date:09/2011).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with morbid obesity and in conjunction with or before bariatric procedure.Approximately eight years and four months post filter deployment, a computed tomography (ct) abdomen and pelvis without intravenous contrast revealed that the filter tilted and filter struts perforated through the inferior vena cava.The device has not been removed and there were no reported attempts made to retrieve the filter.The patient reportedly experienced abdominal pain; however, the current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 FILTER SYSTEM - JUGULAR
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key11075079
MDR Text Key223705011
Report Number2020394-2020-06505
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052578
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 12/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF320J
Device Lot NumberGFSH2013
Was Device Available for Evaluation? No
Date Manufacturer Received12/01/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
LIPITOR AND PROVENTIL; METFORMIN, GLIPIZIDE, JANUVIA AND GABAPENTIN; OMEPRAZOLE, PREDNISONE, TEMAZEPAM AND BACTRIM; PROZAC, GABAPENTIN, IBUPROFEN AND LISINOPRIL
Patient Outcome(s) Other;
Patient Age49 YR
Patient Weight113
-
-